AAM
INSM icon

Aureus Asset Management’s Insmed INSM Stock Holding History

Aureus Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
11,441
+5,441
+91% +$659K 0.07% 113
2026
Q1 		$981K Buy
+6,000
New +$922K 0.07% 113

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Aureus Asset Management's INSM Position: Q2 2026 in Review

Aureus Asset Management increased its Insmed (INSM) stake by 91% in Q2 2026, buying an estimated $659K and bringing the position to 11,441 shares worth $1.22M. The position accounts for 0.07% of the portfolio, ranked #113.

Aureus Asset Management first reported a position in INSM in Q1 2026 and has held it in 2 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Aureus Asset Management held 11,441 shares of Insmed worth $1.22M as of Q2 2026.
  • Aureus Asset Management bought 5,441 Insmed shares in Q2 2026, an estimated $659K.
  • Insmed made up 0.07% of Aureus Asset Management's portfolio in Q2 2026, its #113 holding.
  • Aureus Asset Management first reported a position in Insmed in Q1 2026 and has held it in 2 quarters since.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Aureus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.